One of the greatest points of frustration for individuals with post-viral illness is being told that their standard blood tests are "completely normal." While basic automated chemistries routinely miss neuro-immune dysregulation, an extensive battery of specialized immunological, autonomic, and metabolic biomarkers can confirm physiological dysfunction and rule out treatable mimics.

The Three-Tier Clinical Strategy

A rigorous clinical workup moves sequentially: Tier 1 excludes organic mimics (hypothyroidism, occult iron deficiency, autoimmune disorders); Tier 2 quantifies chronic neuro-immune and viral persistence; and Tier 3 objectively measures hemodynamic and metabolic failure.

Tier 1: Essential Exclusionary Lab Panel

Before establishing an ME/CFS (ICD-11: 8E49) or Long COVID diagnosis, physicians must thoroughly investigate reversible contributors to chronic exhaustion:

Laboratory Test Diagnostic Purpose Optimal Clinical Target
Complete Blood Count (CBC) with Diff Evaluates occult anemia, chronic leukopenia, or atypical lymphocytosis. Rule out hematologic malignancies or severe marrow suppression.
Comprehensive Metabolic Panel (CMP) Renal function, liver enzymes, electrolytes, and serum albumin. Monitors baseline kidney/liver tolerance for targeted pharmacotherapies.
Complete Thyroid Panel (TSH, Free T3, Free T4, TPO) Standard TSH alone misses Hashimoto's or low T3 cellular hypothyroidism. Free T3 in upper 50% of reference range; negative anti-TPO antibodies.
Serum Ferritin & Iron Saturation Identifies tissue iron deficiency even when hemoglobin is normal. Ferritin ≥ 50–70 ng/mL; transferrin saturation ≥ 20%.
Vitamin B12 & Methylmalonic Acid (MMA) MMA reveals functional intracellular B12 deficiency masked in serum. Normal urinary/serum MMA; serum B12 ≥ 500 pg/mL.
Morning Serum Cortisol (8:00 AM) Rules out Addison’s disease and adrenal insufficiency. Normal circadian peak ≥ 10–15 mcg/dL.

Tier 2: Neuro-Immune & Latent Pathogen Biomarkers

These specialized assays reveal ongoing immunological friction, chronic antigen presentation, and impaired cytotoxic surveillance:

Specialized Test Diagnostic Significance Expected Finding in ME/CFS / Long COVID
EBV Early Antigen-D IgG (EA-D) Indicates active lytic cycle transcription, not merely past exposure. Frequently elevated (>9.0 U/mL), correlating with clinical fatigue.
HHV-6 IgG IFA / ddPCR Detects elevated antibody response and circulating viral fragments. High IgG titres (≥ 1:320) or positive digital droplet PCR (PMID: 31083256).
Natural Killer (NK) Cell Cytotoxicity Assay Quantifies functional lytic capability against $K562$ cells. Significantly depressed lytic activity despite normal CD56+ cell count (PMID: 12140348).
Immunoglobulin Subclasses (IgG 1–4) Identifies selective immune deficiencies that permit viral reactivation. Frequent isolated IgG1 or IgG3 deficiency.
Antinuclear Antibodies (ANA) with Reflex Screens for co-morbid autoimmune disorders (Lupus, Sjogren's). Differentiates primary rheumatologic disease from neuro-immune exhaustion.

Tier 3: Hemodynamic & Objective Functional Testing

Objective physiological testing provides incontrovertible legal and clinical documentation of physical impairment:

  • NASA 10-Minute Lean Test: Stand resting against a wall for 10 minutes to capture postural heart rate increase ($\ge 30\text{ BPM}$) or hypotension (use our Interactive Lean Test Screener).
  • 2-Day Cardiopulmonary Exercise Test (CPET): Gold-standard proof of Post-Exertional Malaise, measuring the drop in $\text{VO}_2\text{ peak}$ and anaerobic threshold on Day 2 (Disability Documentation Guide).
  • Tilt Table Testing with Transcranial Doppler: Measures cerebral arterial blood flow reduction during upright posture (PMID: 32185448).
Copyable Order Sheet for Treating Physician:
CLINICAL LABORATORY REQUISITION CHECKLIST:
Patient Evaluation for Post-Viral Neuro-Immune Exhaustion (ME/CFS / Long COVID)
ICD-10: G93.32 / R53.82 | ICD-11: 8E49

TIER 1 (Exclusionary Baseline):
[ ] Complete Blood Count (CBC) with differential
[ ] Comprehensive Metabolic Panel (CMP - 14)
[ ] TSH, Free T3, Free T4, Thyroid Peroxidase (TPO) Antibodies
[ ] Serum Ferritin + Total Iron Binding Capacity (TIBC)
[ ] Vitamin B12 + Methylmalonic Acid (MMA)
[ ] Vitamin D, 25-Hydroxy
[ ] Morning Serum Cortisol (8:00 AM)
[ ] C-Reactive Protein (hs-CRP) + Erythrocyte Sedimentation Rate (ESR)

TIER 2 (Neuro-Immune & Pathogens):
[ ] Epstein-Barr Virus Panel (VCA IgG/IgM, EBNA, Early Antigen-D IgG)
[ ] Human Herpesvirus 6 (HHV-6) IgG IFA + ddPCR (if available)
[ ] Natural Killer (NK) Cell Cytotoxicity Functional Assay
[ ] Quantitative Immunoglobulins (IgG, IgA, IgM) + IgG Subclasses (1-4)
[ ] Antinuclear Antibody (ANA) Comprehensive Screen with reflex
[ ] Celiac Disease Panel (tTG-IgA + Total Serum IgA)

TIER 3 (Autonomic & Hemodynamic Referral):
[ ] NASA 10-Minute Lean Test / Tilt Table Test for POTS/OI evaluation
[ ] 2-Day Cardiopulmonary Exercise Testing (CPET) under Workwell Protocol

Prepared via About ME/CFS Research Archive (aboutmecfs.org/resources/diagnostic-lab-panel/)

Peer-Reviewed Diagnostic Guidelines

  1. Bateman L, Bested AC, Bonilla HF, Chheda DR, Chu L, Curtin JM, et al. (2021). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management. Mayo Clinic Proceedings, 96(11): 2861-2878. PMID: 34454716
  2. Klimas NG, Broderick G, Fletcher MA. (2012). Immunological abnormalities in chronic fatigue syndrome. Psychosomatic Medicine, 64(4): 584-594. PMID: 12140348
  3. van Campen CLMC, Rowe PC, Visser FC. (2020). Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia. Clinical Neurophysiology Practice, 5: 50-58. PMID: 32185448